why is tirzepatide no longer available Long-Term Safety of Tirzepatide: What Research and Experts Reveal IMPORTANT ANNOUNCEMENT - Tirzepatide is

Prescription fills for semaglutide, the generic name for Ozempic, Wegovy, and Rybelsus, increased by more than 400% between January 2021 and December 2023

Nausea, vomiting, diarrhea and other side effects could make it difficult to exercise and follow a healthy lifestyle

In the United States and Europe, however, semaglutide is expected to remain under patent protection until the early or mid-2030s, as is Eli Lillys once-weekly rival injectable tirzepatide (Mounjaro for diabetes and Zepbound for weight loss)

Consult your healthcare provider to discuss possible adjustments, such as modifying the dosage, evaluating your diet and lifestyle factors, or considering alternative treatment options